Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-23-004206
Filing Date
2023-03-20
Accepted
2023-03-20 17:02:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20230320xdefa14a.htm DEFA14A 17344
2 GRAPHIC tmb-20230320xdefa14a_bg001.jpg GRAPHIC 140423
3 GRAPHIC tmb-20230320xdefa14a_bg002.jpg GRAPHIC 109852
  Complete submission text file 0001558370-23-004206.txt   363200
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35565 | Film No.: 23747043
SIC: 2834 Pharmaceutical Preparations